A detailed history of Wells Fargo & Company transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 17,027 shares of TMCI stock, worth $133,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,027
Previous 19,215 11.39%
Holding current value
$133,321
Previous $127,000 22.83%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.01 - $8.45 $10,961 - $18,488
-2,188 Reduced 11.39%
17,027 $98,000
Q2 2024

Aug 13, 2024

BUY
$4.17 - $12.62 $14,974 - $45,318
3,591 Added 22.98%
19,215 $127,000
Q1 2024

May 10, 2024

BUY
$11.48 - $15.86 $33,969 - $46,929
2,959 Added 23.36%
15,624 $203,000
Q4 2023

Feb 09, 2024

BUY
$6.03 - $12.88 $12,777 - $27,292
2,119 Added 20.09%
12,665 $161,000
Q3 2023

Nov 13, 2023

SELL
$12.16 - $24.87 $128,227 - $262,254
-10,545 Reduced 50.0%
10,546 $138,000
Q2 2023

Aug 15, 2023

BUY
$23.91 - $27.81 $263,273 - $306,215
11,011 Added 109.24%
21,091 $539,000
Q1 2023

May 12, 2023

BUY
$20.23 - $26.22 $182,515 - $236,556
9,022 Added 852.74%
10,080 $253,000
Q4 2022

Feb 13, 2023

SELL
$20.54 - $24.67 $330,837 - $397,359
-16,107 Reduced 93.84%
1,058 $24,000
Q3 2022

Nov 14, 2022

BUY
$14.71 - $24.18 $238,228 - $391,595
16,195 Added 1669.59%
17,165 $379,000
Q2 2022

Aug 12, 2022

SELL
$12.93 - $20.29 $350,984 - $550,772
-27,145 Reduced 96.55%
970 $14,000
Q1 2022

May 16, 2022

SELL
$16.73 - $21.58 $109,129 - $140,766
-6,523 Reduced 18.83%
28,115 $531,000
Q4 2021

Feb 14, 2022

SELL
$15.48 - $26.52 $1.22 Million - $2.09 Million
-78,689 Reduced 69.44%
34,638 $646,000
Q3 2021

Nov 15, 2021

BUY
$24.15 - $30.5 $961,508 - $1.21 Million
39,814 Added 54.16%
113,327 $3.05 Million
Q2 2021

Aug 16, 2021

BUY
$25.53 - $36.11 $1.88 Million - $2.65 Million
73,513 New
73,513 $2.3 Million

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $434M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.